Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Analyte Specific Reagents for Cystic Fibrosis

By HospiMedica staff writers
Posted on 08 Jul 2002
New analyte specific reagents (ASRs) are designed to detect the 25 gene mutations most commonly associated with cystic fibrosis (CF).

CF is one of the most common genetic disorders in Caucasian populations of European descent, carried in about one in 29 Caucasians. More...
May medical experts recommend that all women contemplating pregnancy should be offered a screen of the CF gene, CFTR, by their doctors. The CF ASRs may be used by laboratories to screen and genotype individuals for mutations in the CFTR gene. The assays can be performed on the NanoChip Molecular Biology Workstation of Nanogen, Inc. (San Diego, CA, USA), which developed the reagents. Nanogen says this is the first microarray capable of performing such an analysis of the CFTR gene

"In less then nine months, we have delivered on our promise to design what is thought to be one of the most complex genetic assays being performed today into highly accurate, cost-effective and simple-to-use ASRs,” said Dr. Randy White, CEO of Nanogen. "We believe we are well positioned to enter the CF testing market with the NanoChip System due to several competitive factors favoring its adoption.”




Related Links:
Nanogen

Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Gold Member
Blood Gas Analyzer
i-Check200
Syringe Pump
SP50 Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.